P509 RESLIZUMAB AN INTERLEUKIN-5 ANTAGONIST MONOCLONAL ANTIBODY FOR UNCONTROLLED CHRONIC RHINOSINUSITIS WITH NASAL POLYPS

Autor:	S. Nsouli
Rok vydání:	2020
Předmět:	Pulmonary and Respiratory Medicine business.industry Chronic rhinosinusitis medicine.drug_class Immunology Antagonist medicine.disease Monoclonal antibody Reslizumab Immunology and Allergy Medicine Nasal polyps business Interleukin 5 medicine.drug
Zdroj:	Annals of Allergy, Asthma & Immunology. 125:S49-S50
ISSN:	1081-1206
DOI:	10.1016/j.anai.2020.08.167
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b0c9720e9b2d361e619408d715f2ac1b https://doi.org/10.1016/j.anai.2020.08.167 Zobrazit plný text záznamu